ekgs, stress tests and echos · an ekg is a recording of the electrical activity of the heart. •...
TRANSCRIPT
-
EKGs, Stress Tests and Echos
Valerie R. Kaufman, MD, DBIM, FACCVice President & Medical Director
September 2018
Michael Hill, FALU, FLMI, ARA, ACSDirector, Underwriting
-
2
Underwriting Cardiac Disease
Template from www.presentationmagazine.com
-
3
. . . Putting the Pieces Together
-
4
Agenda
Review of cardiac anatomy and physiology
EKG overview
Stress test overview
NTproBNP interlude
Echocardiogram overview
Case studies
-
5
Pre-Test! True or False?
1. The EKG is no longer a useful risk-assessment tool since echocardiograms and BNP are widely available.
2. An inadequate increase in heart rate (less than 85% predicted maximum) invalidates the findings on a regadenosine (Lexiscan) stress test.
3. NTproBNP is only elevated in heart failure.
4. The echocardiogram gives a real-time view of the motion of the myocardium and cardiac valves.
-
6
Anatomy of the Heart
Author: Ties van Brussel Wikipedia Author: ZooFari Wikipedia
The heart is fixed within the body by the major vessels attached to it and by the fibrous skeleton provided by the heart valves and their supporting annuli. The ventricles and atria are free to enlarge and contract against the fixed plane.
http://upload.wikimedia.org/wikipedia/commons/e/e0/Heart_diagram-en.svghttp://upload.wikimedia.org/wikipedia/commons/e/e0/Heart_diagram-en.svghttp://commons.wikimedia.org/wiki/User:ZooFari
-
7
The conduction system of the heart consists of specialized fibers that are adapted to the conduction of the electrical impulse at a much faster rate than that of muscle tissue. The SA node generates an impulse which spreads throughout the atria and on to the AV node. The AV node reconstitutes the impulse and delays transmission to the ventricles to allow the atria to finish contracting.
Conduction System of the Heart
Author : Madhero88 - Wikipedia
http://commons.wikimedia.org/wiki/User:Madhero88
-
8
Cardiac Cycle
Author: Kalumet, selbst erstellt, 28.11.2005. - Wikipedia
Electrical• SA node fires• Impulse spreads throughout atria and to AV node• AV node reconstitutes/slows• Impulse enters Bundle of His, bundle branches, Purkinje
fibers
• Conduction system repolarizes
Mechanical• Atria contract (systole)• Pressure increases in ventricles, closing mitral and tricuspid
valves; atria relax (diastole)
• Ventricles contract (systole); aortic and pulmonic valves open• Ventricles relax (diastole), aortic and pulmonic valves close• Mitral and tricuspid valves open and ventricles fill passively • Atrial “kick” contributes 10-15% of cardiac output
http://commons.wikimedia.org/wiki/User:Kalumet
-
9
The Hard-Working Heart
The myocardium is constantly working• Pumps about 5 liters of blood/minute• About 100,000 heartbeats/day• Pumps about 2,600 gallons of blood/day
The coronary arteries must provide adequate oxygen and nourishment
Cardiac reserve• Cardiac output may be increased to as much as 35 liters/minute • Normal coronary arteries can increase myocardial blood supply 5-6 fold if needed• Early stages of disease of the heart often associated with reduced cardiac reserve• Cardiac reserve diminishes with aging• Atrial fibrillation reduces cardiac output by 10-15%
-
10
Categories of Cardiac Disease
Coronary artery disease
Valvular heart disease
Cardiomyopathy
Congenital heart disease
Hypertensive heart disease
Primary arrhythmias
-
11
The ElectrocardiogramEKG, ECG
-
12
Electrocardiogram (EKG, ECG) An EKG is a recording of the electrical activity of the heart.
• 12 different leads “look” at this activity from different perspectives• Voltage is graphed against time• Voltage polarity (negative or positive) indicates direction of the flow of the electrical impulse
The EKG’s primary purpose is to determine the heart rate and rhythm• Rate: how fast the heart is beating• Rhythm: determines the origin of the pacing impulse and the integrity of the conduction system
The EKG can give indirect information about other conditions• Ischemia • Infarction or other scarring• Hypertrophy• Electrolyte imbalance, drug effects• Pericarditis• Heart position in the chest (COPD, dextrocardia, chest wall deformities)
-
13
EKG Waves and Complexes
Created by Agateller (Anthony Atkielski), converted to svg by atom. - Wikipedia
The P wave corresponds with atrial activation. The PR interval is the time from the activation of the atria to the activation of the ventricles. It indicates the time it takes the impulse generated in the SA node to travel through the atria, into and out of the AV node.
This is followed by the QRS complex (Q, R and S waves), which corresponds to the activation of the ventricle.
The ST segment and T wave correspond with ventricular repolarization.
The QT interval is the time it takes for ventricular activation and repolarization.
http://en.wikipedia.org/wiki/User:Agatellerhttp://cs.wikipedia.org/wiki/Wikipedista:atom
-
14
EKGs Were First Developed in 1903
Einthoven’s EKG rig. 1903 (3 leads), public domain - Wikipedia
EKGs were first developed by Willem Einthoven in Holland. Einthoven used a light projected on a moving mirror and reflected on a fluorescent plane to visualize the EKG.
-
15
The standard positioning of the EKG leads is not random. The leads are arranged in a standard way designed to provide adequate and consistent EKG readings. This consistency is required for pattern recognition and interpretation of the EKGs.
The EKG Waves
P wave, atrial contraction starts
QRS complex, ventricular contraction
T wave, ventricular contraction ends
-
16
Underwriting EKG Findings
Considerations• EKG findings provide direct information about the electrical activity of the heart only • Normal variants must be differentiated from potentially abnormal findings• EKG findings should be interpreted in context of other available information
The Questions • Is it a new finding?• Any other findings on the EKG?• Is there a known history of cardiac disease, and has there been any cardiac evaluation?• What other medical history is there?• What are the potential causes?• What are the potential complications?
-
17
Case Study: Right Bundle Branch Block (RBBB)
62-year-old man, nonsmoker, 6’2, 212 lbs (BMI 27.2)
Sent to reinsurance due to EKG• Known to have a RBBB for at least 7 years (found on screening EKG)• No cardiac symptoms or history• No significant medical history
-
18
Rabbit Ears
-
19
Underwriting EKGs: The Questions
Is it a new finding?
Any other findings on the EKG?
Is there a known history of cardiac disease, and has there been any cardiac evaluation?
What other medical history is there?
What are the potential causes?
What are the potential complications?
-
20
Causes of RBBB
Conduction system disease
CAD, especially involving right coronary artery
Right ventricular hypertrophy
Pulmonary embolism
Congenital heart disease (especially Tetralogy of Fallot, ASD)
Myocarditis/Cardiomyopathy
HTN
-
21
Underwriting EKGs: The Questions
Is it a new finding?
Any other findings on the EKG?
Is there a known history of cardiac disease, and has there been any cardiac evaluation?
What other medical history is there?
What are the potential causes?
What are the potential complications?
No, present x 7 years
No
Nothing significant
No history of cardiac disease, no evaluation
Conduction system disease
Progressive conduction system disease, underlying heart disease
-
22
Stress Tests
-
23
Stress Testing
Purpose: To assess ability of coronary arteries to increase flow compared to rest/baseline. Can be used to screen for or to follow known CAD.
Stress (increases demand or causes flow differential)• Exercise by treadmill or bicycle - increases heart rate, BP and contractile state• Dobutamine – works much like exercise to increase heart rate, BP and contractile state• Vasodilators – adenosine, regadenosine (Lexiscan), dipyridamole
Monitoring for results• EKG• Echo• Nuclear (MPI)
-
24
Vasodilator Stress Tests
Includes adenosine/regadenosine and dipyridamole
Mechanism • Dilate coronary arteries• Flow increases more in normal vessels than in diseased vessels• Relative differences in perfusion show up on imaging• Rarely induce actual ischemia• Often combined with low level walking as this may reduce side effects
How differs from exercise stress test• Heart rate and BP not expected to increase significantly• EKG not expected to show ischemic changes• Symptoms more likely to be side effect of drug than due to ischemia
-
25
Stress Testing as a Screen for CAD
Accuracy of any screening test depends on • Prevalence of disease • Sensitivity and specificity of test
Sensitivity = True positive rate
Specificity = True negative rate
Exercise EKG: Sensitivity and specificity in the range of 60 – 75%
Imaging studies: Sensitivity and specificity in the range of 80 – 90%
-
26
Stress Testing in Known CAD
Indicated to assess significance of new symptoms
Could be considered • Evaluation of incomplete revascularization• Assessment of the adequacy of medical therapy• Need to evaluate coronary status in anticipation of major noncardiovascular surgery
Should not expect “routine” follow up stress testing in stable CAD
Fihn SD, Gardin JM et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force, American Association of Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164.
-
27
The Exercise EKG – More Than ST Segments!
Exercise capacity: duration and amount of exertion
BP response
Symptoms
ST segment changes
Arrhythmias
Heart rate recovery
-
28
Interpreting Stress Tests
Type of Test Component Criteria for Positive Test Other Adverse Findings
Exercise or Dobutamine
EKG • ST depression• Anginal pain
• ↓ Exercise capacity• Abnormal BP response• Arrhythmias
Nuclear imaging
• Reversible perfusion defect• Transient regional wall motion
abnormality
• LV dilatation• Fixed perfusion defect• Failure to increase EF
Echo imaging • Transient regional wall motion abnormality
• Failure to increase EF
• LV dilatation• Fixed wall motion abnormality• Valvular dysfunction
Vasodilator(regadenosine, dipyridamole)
• Positive imaging findings• Do NOT expect EKG changes
• Symptoms such as CP, SOB –often side effect from drug rather than due to ischemia
-
29
Not All ST Depression is CAD . . .
Causes of ST depression on exercise EKG• CAD• Hypertensive blood pressure response• LVH• Cardiomyopathy• Bundle branch block• Other depolarization abnormalities, like pre-excitation (such as WPW)• Electrolyte imbalance
-
NTproBNP
Wikimedia Commons, CC 3.0. Author OpenStax College. Anatomy & Physiology, Connexions Website. http://cnx.org/content/col11496/1.6/
http://cnx.org/content/col11496/1.6/
-
31
Natriuretic Peptides Family of peptides
• ANP: Atrial natriuretic peptide (1983)• BNP: Brain (or B-type) natriuretic peptide (1988)• CNP: C-type or vascular natriuretic peptide (1990)• DNP: D-type natriuretic peptide (early 1990s)
Effects• Natriuretic• Diuretic• Vasodilator• Antiproliferative
Play role in • Regulation of blood pressure• Regulation of plasma volume• Attenuation of cardiac hypertrophy
-
32
B-Type (Brain) Natriuretic Peptides Made by myocardial cells
Stored as a prohormone: proBNP
When released, is cleaved into 2 fragments• BNP – biologically active, short half-life• NTproBNP – not biologically active, but long half-life and stable at room temperature
Normally present in small quantities in the blood
Released in increased amounts in response to wall stress (pressure, stretch)
May be used clinically to follow status of known cardiac disease
Correlates with cardiovascular and all-cause mortality
Brain image: Pixabay, free for commercial use, no attribution required
-
33
ProBNP, BNP and NTproBNP
NTproBNP
ProBNP
BNP
-
34
NTproBNP May Be Elevated In
Heart failure
CAD
Cardiomyopathy
Valvular heart disease
Congenital heart disease
Secondary LVH
Atrial fibrillation
Advancing age
Anemia
Renal failure
Pulmonary HTN
Bacterial sepsis
Severe burns
Toxic insults such as chemotherapy or envenomation
-
35
Clinical Utilization of BNP/NTproBNP
To help determine if acute SOB is due to a cardiac or noncardiac cause
To help confirm diagnosis of heart failure
To follow status and response to treatment
To assess risk for development of clinical heart failure
-
36
NTproBNP and Mortality
Predicts cardiovascular and all-cause mortality
Predicts mortality independent of • Traditional cardiac risk factors• Ejection fraction
Studied clinically in healthy community-dwelling populations in the U.S. and in Europe
Single measurement is predictive, serial measurements add value
Stable at room temperature and does not require special handling
-
37
The Appeal of NTproBNP in Insurance Screening
May be ↑ in many types of cardiac disease • Before heart failure develops• Even before clinical onset of cardiac disease
o As much as 75% systolic dysfunction in the community is undetectedo Diastolic dysfunction even less likely to be detectedo About 500,000 people in the U.S. have HCM and most are unawareo Most heart diseases are asymptomatic in early stages
Predicts all cause mortality, even after adjusting for traditional risk factors
Obtained by simple blood draw; stable in transit
Cost is acceptable
-
38
Utilization of NTproBNP in Insurance Insurance labs have been offering for >10 years
In place of stress tests
As additional age-and-amount testing requirement
In place of ECGs
To support automated underwriting systems
Challenge: how to interpret NTproBNP values and assign mortality risk
-
39
Mortality Ratio for All-Cause Mortality
0
100
200
300
400
500
600
700
800
1000
Male age 50-69 Male age 70-89 Female age 50-69 Female age 70-89
Fulks M, Kaufman V et al. NT-proBNP predicts all-cause mortality in a population of insurance applicants, follow-up analysis and further observations. J Insur Med 2017;47:4
-
40
Clinical Reference Laboratory Study 2017
NTproBNP(in pg/ml)
≤ 75 (ref) 76-175 176-300 301-500 501-1000 > 1000
MenAge 50-69
1 1.85 2.54 6.55 6.63 16.15
MenAge 70-89
1 1.72 2.84 3.23 5.07 7.17
WomenAge 50-69
1 0.88 1.58 2.65 4.11 8.24
WomenAge 70-89
1 1.49 1.96 2.29 4.14 7.7
Relative Risk for All-Cause Mortality by NTproBNP Level
Fulks M, Kaufman V et al. NT-proBNP predicts all-cause mortality in a population of insurance applicants, follow-up analysis and further observations. J Insur Med 2017;47:4
-
41
Clinical Reference Laboratory Study 2017
Age ≤ 75 ≤ 175 ≤ 300 ≤ 500 ≤ 1000
MEN
50-59 90.8% 98.5% 99.4% 99.8% 99.9%
60-69 76.2% 94.3% 97.6% 98.8% 99.6%
70-79 52.2% 82.4% 91.8% 95.9% 98.5%
WOMEN
50-59 74.4% 96.6% 99.3% 99.8% 100%
60-69 57.5% 89.1% 97.0% 99.0% 99.7%
70-79 34.8% 72.6% 88.7% 95.5% 98.7%
Fulks M, Kaufman V et al. NT-proBNP predicts all-cause mortality in a population of insurance applicants, follow-up analysis and further observations. J Insur Med 2017;47:4
Cumulative Distribution of NTproBNP (pg/ml) Values by Age and Sex*
*For applicants denying heart disease
-
42
NTproBNP and ECGs
Different screening tools that detect different risks
Potential advantages of NTproBNP over ECGs• Cheaper• May be added to regular insurance blood profile• Fewer quality issues• Does not require interpretation by specially trained staff• May better facilitate automation
Caveats• Not “equivalent” to the ECG• Requires development of new guidelines• Mortality slippage can occur if cutpoints and guidelines not aligned to expectations
-
43
The Echocardiogram
Author: Kjetil Lenes Wikipedia
http://commons.wikimedia.org/wiki/User:Ekko
-
44
Echocardiogram Also known as cardiac ultrasound
Noninvasive
No radiation
Readily available
Provides real time images of the heart
Cost is a consideration
-
45
Traditional Echo Modalities
M mode – 1 dimensional “icepick” view through various planes of the heart • Measure chamber sizes and ventricular wall thickness
2D – 2 dimensional, real-time motion• Measure chamber sizes and ventricular wall thickness
Doppler – assesses characteristics of blood flow• Assess valve function• Assess pressures• Assess for abnormal flow
-
46
Enhancements to Echocardiography
Addition of color
Echo contrast (microbubbles)
Transesophageal approach
Tissue Doppler
3D imaging
Speckle and strain imaging
-
47
M Mode Echo
The computer imaging system calculates sizes and displays them automatically in M mode. The left ventricle is being measured in this example. Also note the timing EKG tracing.
Author: Kjetil Lenes Wikipedia
The small figure in the circle is the 2D echo
http://commons.wikimedia.org/wiki/User:Ekko
-
48
2D Views
These are some of the echocardiographic views available through different transducer positioning. Each view shows only a narrow plane of tissue through the heart. Some of these views can be difficult to obtain depending on the size and shape of the patient’s chest. Some structures can be only be seen in specific views.
Authors: Patrick J. Lynch and C. Carl Jaffe Wikipedia
http://upload.wikimedia.org/wikipedia/commons/4/46/LeftVentricleShortAxis.gifhttp://upload.wikimedia.org/wikipedia/commons/4/46/LeftVentricleShortAxis.gifhttp://upload.wikimedia.org/wikipedia/commons/7/7a/Apical_4_chamber_view.gifhttp://upload.wikimedia.org/wikipedia/commons/7/7a/Apical_4_chamber_view.gifhttp://upload.wikimedia.org/wikipedia/commons/1/16/LeftParasternalLongAxis.gifhttp://upload.wikimedia.org/wikipedia/commons/1/16/LeftParasternalLongAxis.gif
-
49
Doppler Echocardiogram• Doppler of a ventricular septal
defect showing the abnormal flow of blood across the defect in the septum.
• The EKG tracing indicates (red mark) the point of the cycle where this picture was taken.
• Very small defects with little flow may require microbubble contrast enhancement.
Author: Kjetil Lenes Wikipedia
Doppler evaluation of the speed of flow across a valve or septal defect can be used to calculate the size of the valve opening or defect. Higher rates of flow indicate tighter openings and vice versa.
http://commons.wikimedia.org/wiki/User:Ekko
-
50
Echocardiogram 2D and 3D – in motion
Above: Sketch labeling the 3D picture. Mitral and aortic valves on right of image, tricuspid valve left.
Author: Kjetil Lenes Wikipedia
http://commons.wikimedia.org/wiki/User:Ekko
-
51
Information Provided by the Echo
Cardiac chamber sizes and wall thickness
Appearance of the heart valves
Assessment of valvular function and dysfunction
Assessment of systolic and diastolic function of the myocardium
Assessment of presence, direction and speed of blood flow
Estimation of pressures within cardiac chambers
-
52
Limitations of the Echocardiogram
Body habitus• Chest wall deformities such as pectus excavatum and
kyphoscoliosis distort anatomy• Obesity makes it difficult for sound waves to penetrate• Sound waves don’t travel well in air – hyperinflated lungs make it
difficult to acquire clear images (COPD, asthma, ventilator patients)
Be careful when “technically difficult” study
Skill and patience of the examiner and methodology of interpreter
-
53
Normal ValuesStructure Reference Range
LVIDdLVEDD
Left ventricular internal dimension in diastoleLeft ventricular end diastolic dimension
3.9 – 5.3 cm (women)4.2 – 5.9 cm (men)
LVIDsLVESD
Left ventricular internal dimension in systoleLeft ventricular end systolic dimension
IVSd Interventricular septum in diastole 0.6 – 0.9 cm (women)0.6 – 1.0 cm (men)IVSs Interventricular septum in systole
LVPWd Left ventricular posterior wall in diastole 0.6 – 0.9 cm (women)0.6 – 1.0 cm (men)LVPWs Left ventricular posterior wall in systole
LA Left atrium 2.7 – 3.8 cm (women)3.0 – 4.0 cm (men)Lang RM, Bierig M et al. Recommendations for Chamber Quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18;1440-1463.
-
54
Value of the Echo in Different Types of Heart Disease
Type of Disease How an Echo Can Help
Coronary Artery Disease • Regional wall motion abnormalities
Valvular Heart Disease• Valve structure• Degree of dysfunction (stenosis, regurgitation)• Compensatory changes (dilatation, hypertrophy)
Cardiomyopathy • Type and severity
Congenital Heart Disease • Type and severity• Compensatory changes (dilatation, hypertrophy)
Hypertensive Heart Disease • Compensatory changes
Primary Arrhythmias • Excludes structural abnormalities
-
55
Review of Pretest
1. The EKG is no longer a useful risk assessment tool since echocardiograms and BNP are widely available.
2. An inadequate increase in the heart rate (less than 85% predicted maximum) invalidates the findings on a regadenosine (Lexiscan) stress test.
3. NTproBNP is only elevated in heart failure.
4. The echocardiogram gives a real time view of the motion of the myocardium and cardiac valves.
FALSE
TRUE
FALSE
FALSE
-
56
Putting the Pieces Together
Consider all the different types of cardiac disease, not just CAD
Consider all the pieces of evidence available
Recognize the limitations of the various tests
Give more weight to more predictive tests
Go with the “preponderance of the evidence”
Stay focused on assessing risk rather than making a diagnosis
-
57
-
©2018 RGA. All rights reserved.
EKGs, Stress Tests and EchosUnderwriting Cardiac Disease. . . Putting the Pieces TogetherAgendaPre-Test! True or False? Slide Number 6Conduction System of the HeartCardiac CycleThe Hard-Working HeartCategories of Cardiac DiseaseThe Electrocardiogram��EKG, ECGElectrocardiogram (EKG, ECG)EKG Waves and ComplexesEKGs Were First Developed in 1903The EKG WavesUnderwriting EKG FindingsCase Study: Right Bundle Branch Block (RBBB)Rabbit EarsUnderwriting EKGs: The QuestionsCauses of RBBBUnderwriting EKGs: The QuestionsStress TestsStress TestingVasodilator Stress TestsStress Testing as a Screen for CADStress Testing in Known CADThe Exercise EKG – More Than ST Segments! Interpreting Stress TestsNot All ST Depression is CAD . . . NTproBNPNatriuretic PeptidesB-Type (Brain) Natriuretic PeptidesProBNP, BNP and NTproBNPNTproBNP May Be Elevated InClinical Utilization of BNP/NTproBNPNTproBNP and MortalityThe Appeal of NTproBNP in Insurance Screening Utilization of NTproBNP in InsuranceMortality Ratio for All-Cause MortalityClinical Reference Laboratory Study 2017Clinical Reference Laboratory Study 2017NTproBNP and ECGsThe EchocardiogramEchocardiogramTraditional Echo Modalities Enhancements to EchocardiographySlide Number 47Slide Number 48Slide Number 49Slide Number 50Information Provided by the EchoLimitations of the EchocardiogramNormal ValuesValue of the Echo in Different Types of Heart DiseaseReview of Pretest Putting the Pieces TogetherSlide Number 57Slide Number 58